Tech Company Financing Transactions
SomaLogic Funding Round
SomaLogic closed a $81 million Series A financing round on 12/23/2020. Investors included Casdin Capital, Amgen Ventures and Blue Water Life Science Fund.
Transaction Overview
Company Name
Announced On
12/23/2020
Transaction Type
Venture Equity
Amount
$81,000,000
Round
Series A
Investors
Casdin Capital (Lead Investor) (Eli Casdin)
Madryn Asset Management (Avinash Amin)
Proceeds Purpose
The funds raised in this round will facilitate improving, expanding and commercializing SomaLogic's world-leading proteomic products in both the clinical and life science markets.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
2945 Wilderness Pl.
Boulder, CO 80301
USA
Boulder, CO 80301
USA
Phone
Website
Email Address
Overview
SomaLogic, Inc. is developing novel proteomics systems and applications based on its proprietary aptamer technology. Aptamers are single-stranded DNA and RNA molecules that, like antibodies, can bind to target molecules with high affinity and specificity.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Roy Smythe
Chief Medical Officer
Stephen Williams
Chief Operating Officer
Alan Williams
Chief Scientific Officer
Nebojsa Janjic
President
Melody Harris
Browse more venture capital transactions:
Prev: 12/23/2020: ReturnSafe venture capital transaction
Next: 12/23/2020: Atriomx Health venture capital transaction
Share this article
Where The Data Comes From
We do our best to record every notable VC transaction. All VC database entries on this site come from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs